What is Mediar Therapeutics worth?
$230.0Mlast known valuation
Mediar Therapeutics last raised $37.8M in its Early Stage VC (Dec 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 21 names
- ·Watchlist + deal alerts for Mediar Therapeutics
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2025 | Early Stage VC | $37.8M | ▮ | ▮ |
| Nov 2022 | Later Stage VC | $85.0M | ▮ | ▮ |
| Jan 2019 | Early Stage VC | $5.0M | ▮ | ▮ |
How Mediar Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Mediar Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Mediar Therapeutics worth?
- Mediar Therapeutics's last known valuation is $230.0M.
- How much has Mediar Therapeutics raised?
- Mediar Therapeutics has raised $180.3M in total funding across 3 recorded rounds.
- When did Mediar Therapeutics last raise?
- Mediar Therapeutics last raised in Dec 2025 (Early Stage VC), raising $37.8M.